SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme.
Blankenship LR, Yang KS, Vulupala VR, Alugubelli YR, Khatua K, Coleman D, Ma XR, Sankaran B, Cho CD, Ma Y, Neuman BW, Xu S, Liu WR.
Blankenship LR, et al. Among authors: xu s.
ACS Med Chem Lett. 2024 May 20;15(6):950-957. doi: 10.1021/acsmedchemlett.4c00146. eCollection 2024 Jun 13.
ACS Med Chem Lett. 2024.
PMID: 38894905
Free PMC article.